Trial site

NEXT Dallas

Dallas, Texas 75039, United StatesNot linked to an institution yet

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions: Colorectal cancer3 trials
Lung cancer3 trials
Liver and biliary tract cancer2 trials
Bladder cancer1 trial
Gastric and oesophageal cancer1 trial
Melanoma1 trial
Neuroendocrine tumours1 trial
Pancreatic cancer1 trial
Prostate cancer1 trial
Phase: Phase 15 trials
Status: Recruiting5 trials
Lead sponsor: Conjupro Biotherapeutics, Inc.2 trials
Pilatus Biosciences Inc1 trial
Revolution Medicines, Inc.1 trial
SystImmune Inc.1 trial

Recruiting
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
NCT07337525· Phase 1· Pilatus Biosciences Inc· Source
Contact: Mofopefoluwa Akinwale
Recruiting
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
NCT07349537· Phase 1· Revolution Medicines, Inc.· Source
Contact: NEXT TXReferrels
Recruiting
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
NCT07317505· Phase 1· Conjupro Biotherapeutics, Inc.· Source
Contact: Shiraj Sen, MD (principal investigator)
Recruiting
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
NCT07080242· Phase 1· SystImmune Inc.· Source
Contact: Mofopefoluwa Akinwale
Recruiting
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
NCT05948865· Phase 1· Conjupro Biotherapeutics, Inc.· Source
Contact: Shiraj Sen, MD

How many trials recruit for the same indication here at once. A count, not a rating.

Site data: ClinicalTrials.govUpdated 12 Nov 2026